Sandor Victor 4

What Happened
Sandor Victor, a director of ADC Therapeutics (ADCT), was granted 45,000 restricted stock units (RSUs) on 2026-06-01 (grant price $0.00). On 2026-06-03, 12,600 shares were withheld/disposed to satisfy tax withholding obligations at $3.08 per share, totaling $38,808. The grant is a compensation award (not a market purchase), and the share withholding is a tax-related disposition rather than an open-market sale.

Key Details

• Transaction dates and types: 2026-06-01 — RSU grant (Code A) of 45,000 RSUs; 2026-06-03 — shares withheld for tax/payment (Code F) of 12,600 shares @ $3.08 (disposed) = $38,808.
• Grant price: RSUs reported at $0.00 (award).
• Shares owned after transaction: Not specified in the provided Form 4.
• Footnotes:
  • F1: Annual RSU grant under the 2019 Equity Incentive Plan; each RSU converts to one share upon vesting. RSUs vest on the earlier of one year from grant or the 2027 Annual Meeting, subject to continued service.
  • F2: 12,600 shares were withheld by the issuer to satisfy the Reporting Person’s tax withholding obligations in connection with prior RSU vesting.
• Filing timeliness: Report filed 2026-06-03 for transactions with a 2026-06-01 effective date — appears timely under standard Form 4 rules.

Context
RSUs are compensation awards that convert to company shares upon vesting; withholding shares to cover taxes is a routine, administrative step (often a cashless or share-for-tax withholding) and does not necessarily reflect a director selling shares on the open market. This filing records compensation-related activity rather than a market buy or opportunistic sale.